Jane Daniels

ORCID: 0000-0003-3324-6771 · 44 papers in corpus
rct 2026
Reproduction & fertility ·doi:10.1530/raf-26-0043

Endometriosis is a chronic pain condition that affects >190 million people worldwide. It is recommended in clinical guidelines to remove the most common type of endometriosis, 'superficial peritoneal endometriosis' (SPE), if it is diagnosed…

2025
·doi:10.1016/j.lanogw.2025.100028
other 2024
Frontiers in pharmacology ·doi:10.3389/fphar.2024.1460206

INTRODUCTION: Chronic pelvic pain affects up to 24% of women worldwide and for up to 55% of these there is no associated pathology. Despite this there are no established treatments in this cohort. This is a secondary analysis of a randomise…

rct 2024
BMJ open ·doi:10.1136/bmjopen-2024-088072

OBJECTIVES: To evaluate the cost-effectiveness of long-acting progestogens (LAP), including levonorgestrel-releasing intrauterine system (LNG-IUS) and depot-medroxyprogesterone acetate (DMPA), compared with the combined oral contraceptives …

rct 2024
BMJ (Clinical research ed.) ·doi:10.1136/bmj-2023-079006

OBJECTIVES: To evaluate the clinical effectiveness of long acting progestogens compared with the combined oral contraceptive pill in preventing recurrence of endometriosis related pain. DESIGN: The PRE-EMPT (preventing recurrence of endome…

rct 2024
Health technology assessment (Winchester, England) ·doi:10.3310/SQWY6998

BACKGROUND: Endometriosis affects 1 in 10 women, many of whom have surgery for persistent pain. Recurrence of symptoms following an operation is common. Although hormonal treatment can reduce this risk, there is uncertainty about the best o…

other 2023
Trials ·doi:10.1186/s13063-023-07386-x

BACKGROUND: Endometriosis affects 190 million women and those assigned female at birth worldwide. For some, it is associated with debilitating chronic pelvic pain. Diagnosis of endometriosis is often achieved through diagnostic laparoscopy.…

rct 2023
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics ·doi:10.1002/ijgo.14626

OBJECTIVE: To determine treatment options (myomectomy vs. uterine artery embolization (UAE)) for women wishing to avoid hysterectomy. METHODS: A multicenter randomized controlled trial was conducted on 254 women and data were collected on …

rct 2023

BackgroundTubal ectopic pregnancies can cause significant morbidity or even death. Current treatment is with methotrexate or surgery. However, methotrexate treatment can fail in approximately 30% of women. Gefitinib, an epidermal growth fac…

rct 2023

BackgroundHeavy menstrual bleeding affects one in four women and negatively impacts quality of life. The levonorgestrel-releasing intrauterine system is an effective long-term treatment but is discontinued by many due to unpredictable bleed…

rct 2023
EClinicalMedicine ·doi:10.1016/j.eclinm.2023.101995

BACKGROUND: Heavy menstrual bleeding affects one in four women and negatively impacts quality of life. Ulipristal acetate is prescribed to treat symptoms associated with uterine fibroids. We compared the effectiveness of ulipristal acetate …

other 2022
Pain and therapy ·doi:10.1007/s40122-021-00351-z
other 2022
AJOG global reports ·doi:10.1016/j.xagr.2022.100057
observational 2022
The British journal of general practice : the journal of the Royal College of General Practitioners ·doi:10.3399/bjgp.2022.0260

BACKGROUND: Heavy menstrual bleeding (HMB) is a common problem that can significantly affect women's lives. There is a lack of evidence on long-term outcomes after seeking treatment. AIM: To assess continuation rates of medical treatments …

rct 2022
Health technology assessment (Winchester, England) ·doi:10.3310/ZDEG6110

BACKGROUND: Uterine fibroids are the most common tumour in women of reproductive age and are associated with heavy menstrual bleeding, abdominal discomfort, subfertility and reduced quality of life. For women wishing to retain their uterus …

nonrandomized-trial 2021
Pilot and feasibility studies ·doi:10.1186/s40814-021-00797-0

BACKGROUND: Endometriosis (where endometrial-like tissue is found outside the uterus) affects ~ 176 million women worldwide and can lead to debilitating pelvic pain. There is an unmet need for new medical treatment options for endometriosis…

other 2021
Pilot and feasibility studies ·doi:10.1186/s40814-020-00740-9

BACKGROUND: Endometriosis (where endometrial-like tissue is found outside the uterus) affects ~ 176 million women worldwide and can lead to debilitating pelvic pain. Three subtypes of endometriosis exist, with ~ 80% of women having superfic…

rct 2021
European journal of obstetrics & gynecology and reproductive biology: X ·doi:10.1016/j.eurox.2021.100139

OBJECTIVE: To examine the quality of life experienced by women with symptomatic uterine fibroids who had been treated with UAE in comparison to myomectomy. We report the four-year follow-up of the FEMME randomised trial. Two-year follow-up …

rct 2020
Lancet (London, England) ·doi:10.1016/s0140-6736(20)31693-7

BACKGROUND: Chronic pelvic pain affects 2-24% of women worldwide and evidence for medical treatments is scarce. Gabapentin is effective in treating some chronic pain conditions. We aimed to measure the efficacy and safety of gabapentin in w…

rct 2020

Background Chronic pelvic pain (CPP) affects 2-24% of women worldwide and evidence for medical treatments is limited. Gabapentin is effective in treating some chronic pain conditions. We aimed to determine the efficacy and safety of gabapen…

other 2020
Human reproduction open ·doi:10.1093/hropen/hoaa012

STUDY QUESTION: Is it feasible to undertake a randomised controlled trial to establish whether surgical removal of endometrioma or not, improves live birth rates from IVF? SUMMARY ANSWER: A randomised controlled trial (RCT) comparing surge…

other 2019
BJOG: An International Journal of Obstetrics & Gynaecology ·doi:10.1111/1471-0528.15894

Endometriosis is a potentially life-altering, estrogen-dependent condition which is associated with chronic pelvic pain. It affects an estimated 176 million women worldwide, making it as common as diabetes mellitus (DM).1 The socio-economic…

2018
·doi:10.60692/6nvwt-mjd92

Chronic pelvic pain (CPP) affects more than 1 million UK women with associated healthcare costs of £158 million annually. Current evidence supporting interventions when no underlying pathology is identified is very limited and treatment is …

rct 2018
BMJ open ·doi:10.1136/bmjopen-2016-014924

INTRODUCTION: Chronic pelvic pain (CPP) affects more than 1 million UK women with associated healthcare costs of £158 million annually. Current evidence supporting interventions when no underlying pathology is identified is very limited and…

diagnostic-accuracy 2018
Health technology assessment (Winchester, England) ·doi:10.3310/hta22400

BACKGROUND: Chronic pelvic pain (CPP) symptoms in women are variable and non-specific; establishing a differential diagnosis can be hard. A diagnostic laparoscopy is often performed, although a prior magnetic resonance imaging (MRI) scan ma…